Use of anti-osteoporosis drugs in type 2 diabetic patients: A population-based cohort study

Use of anti-osteoporosis drugs in type 2 diabetic patients: A population-based cohort study

Detalhes bibliográficos
Principais autores:	Martinez-Laguna, D, Carbonell-Abella, C, Soria-Castro, A, Nogues, X, Diez-Perez, A, Prieto-Alhambra, D
Formato:	Conference item
Publicado em:	Springer 2017

Registros relacionados

Use of drugs for osteoporosis treatment in patients with type 2 diabetes mellitus: Population-based cohort study
por: Martínez-Laguna, D, et al.
Publicado em: (2017)

2-year persistence with different anti-osteoporosis medications: a population-based cohort
por: Reyes, C, et al.
Publicado em: (2017)

Uso de fármacos para la osteoporosis en pacientes con diabetes mellitus tipo 2: estudio de cohortes de base poblacional
por: Martínez-Laguna D, et al.
Publicado em: (2017-11-01)

Excess of all-cause mortality after a fracture in type 2 diabetic patients: a population-based cohort study
por: Martinez-Laguna, D, et al.
Publicado em: (2017)

One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study.
por: Reyes, C, et al.
Publicado em: (2017)

Long-term (up to 5 years) persistence with different anti-osteoporosis medications in Catalonia (Spain): a population-based cohort study
por: Carbonell, C, et al.
Publicado em: (2013)

Riesgo de fractura asociado a los estadios previos al diagnóstico de diabetes mellitus tipo 2: Estudio de casos-controles anidados (cohorte DIAFOS)
por: Martínez-Laguna D, et al.
Publicado em: (2013-06-01)

1 and 2-year persistence with different anti-osteoporosis medications per previous use and setting of therapy initiation: A population-based cohort study
por: Reyes, C, et al.
Publicado em: (2017)

Hip Fracture In Early Stages of Type 2 Diabetes: A Population-Based Cohort Study
por: Prieto-Alhambra, D, et al.
Publicado em: (2013)

Validation of fragility fractures in primary care electronic medical records: a population-based study
por: Martinez-Laguna, D, et al.
Publicado em: (2016)

El papel de la determinación de un marcador de resorción, el telopéptido carboxiterminal del colágeno I, en la valoración del cumplimiento terapéutico en pacientes tratadas con bifosfonatos orales
por: Martínez-Laguna D, et al.
Publicado em: (2019-03-01)

Validation of fragility fractures in primary care electronic medical records: a population-based study
por: Martinez-Laguna, D, et al.
Publicado em: (2017)

Mortality, falls and fracture risk are positively associated with frailty: a SIDIAP cohort study of 890,000 patients
por: Middleton, R, et al.
Publicado em: (2021)

The association between type 2 diabetes mellitus, hip fracture, and post-hip fracture mortality: a multi-state cohort analysis
por: Tebé, C, et al.
Publicado em: (2019)

Incident type 2 diabetes and hip fracture risk: a population-based matched cohort study.
por: Martinez-Laguna, D, et al.
Publicado em: (2015)

PERSISTENCE WITH DIFFERENT ANTIOSTEOPOROSIS MEDICATIONS: A POPULATION-BASED COHORT STUDY
por: Carbonell-Abella, C, et al.
Publicado em: (2013)

Insulin use and excess fracture risk in patients with type 2 diabetes: a propensity-matched cohort analysis
por: Losada-Grande, E, et al.
Publicado em: (2017)

"Burden of osteoporotic fractures in primary health care in Catalonia (Spain): a population-based study".
por: Pagès-Castellà, A, et al.
Publicado em: (2012)

Fracture risk in type 2 diabetic patients: a clinical prediction tool based on a large population-based cohort
por: Martínez-Laguna, D, et al.
Publicado em: (2018)

Insulin use and excess fracture risk among type 2 diabetic patients: a propensity-matched cohort analysis
por: Losada-Grande, E, et al.
Publicado em: (2016)

The association between fracture and obesity is site-dependent: a population-based study in postmenopausal women.
por: Prieto-Alhambra, D, et al.
Publicado em: (2012)

Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case–control study
por: Losada, E, et al.
Publicado em: (2018)

Deep learning to detect features of a population of anti-osteoporosis drug users
por: Khalid, S, et al.
Publicado em: (2018)

Assessment of cardiovascular safety of anti-osteoporosis drugs
por: Fuggle, NR, et al.
Publicado em: (2020)

ASSOCIATION BETWEEN FRACTURE SITE AND OBESITY IN MEN: A POPULATION-BASED STUDY
por: Premaor, M, et al.
Publicado em: (2013)

The association between type 2 diabetes mellitus, hip fracture, and post-hip-fracture mortality: a multi-state cohort analysis
por: Tebe, C, et al.
Publicado em: (2017)

Deep learning for drug utilisation research: Identifying features within a population of anti-osteoporosis drug users
por: Khalid, S, et al.
Publicado em: (2018)

HIV infection is strongly associated with hip fracture risk, independently of age, gender, and comorbidities: a population-based cohort study.
por: Güerri-Fernandez, R, et al.
Publicado em: (2013)

Characterising anti-osteoporosis drug users in real world primary care settings in Spain: A data-driven cluster analysis
por: Khalid, S, et al.
Publicado em: (2017)

“Burden of osteoporotic fractures in primary health care in Catalonia (Spain): a population-based study”
por: Pagès-Castellà Aina, et al.
Publicado em: (2012-05-01)

Comparative anti-fracture effectiveness of different anti-osteoporosis medications amongst male drug users in real world clinical practice: a population-based cohort study
por: Zwart, M, et al.
Publicado em: (2016)

Risk of venous thromboembolism amongst users of different anti-osteoporosis drugs: a multinational population-based cohort study
por: Martin-Merino, E, et al.
Publicado em: (2016)

Riesgo de fractura según FRAX®, hipovitaminosis D, y calidad de vida en una población con fractura osteoporótica atendida en Atención Primaria: descriptiva basal de la cohorte VERFOECAP
por: Martínez-Laguna D, et al.
Publicado em: (2011-11-01)

Insulin use and Excess Fracture Risk in Patients with Type 2 Diabetes: A Propensity-Matched cohort analysis
por: Eladio Losada-Grande, et al.
Publicado em: (2017-06-01)

Comparison of the effects of exemestane versus letrozole on bone loss: A cohort study
por: Prieto-Alhambra, D, et al.
Publicado em: (2011)

Antidiabetic medication use and the risk of fracture in type 2 diabetic patients: a nested case-control study
por: Prieto-Alhambra, D, et al.
Publicado em: (2017)

Erratum to: The impact of common co-morbidities (as measured using the Charlson index) on hip fracture risk in elderly men: A population-based cohort study (Osteoporosis International DOI: 10.1007/s00198-014-2682-9)
por: Reyes, C, et al.
Publicado em: (2014)

Sub-groups of anti-osteoporosis drug users, and associated fracture risk in real world primary care settings: a data-driven cluster analysis
por: Khalid, S, et al.
Publicado em: (2017)

Impacto socioeconómico de la osteoporosis
por: Nogués Solán X, et al.
Publicado em: (2010-07-01)

Association of tramadol vs codeine prescription dispensation with mortality and other adverse clinical outcomes
por: Xie, J, et al.
Publicado em: (2021)